Virology Days 2012: Programme

This programme is published on the 2nd of March. There might come some minor changes to it.

Thursday, 22 March 2012

10:30 -12:00   Registration
11:30 -12:30    Lunch
12:30 -12:40    Welcome / Introductory comments
12:40 -14:30    Session I: Molecular virology 1

Maija Vihinen-Ranta (University of Jyväskylä): Nuclear envelope – final barrier for DNA viruses.
Janne Tynell (THL): Nuclear export of influenza A virus NS1 protein.
Amirbabak Sioofy Khojine (University of Tampere): Interaction between Coxsackievirus B1 with innate immune system in peripheral blood mononuclear cells.
Eeva Auvinen (University of Helsinki):
Biological validation of cellular microRNA alterations caused by human papillomavirus 16 E5 oncogene.
Varpu Marjomäki (University of Jyväskylä): Echovirus 1 induced non-recycling endosomal pathway leading to enhanced integrin down-regulation.
Pirjo Merilahti (University of Turku): Role of beta1-integrin, beta2-microglobulin and heparan sulfate in cellular infection of human parechovirus 1.

14:30 -15:00    Coffee break and exhibition
15:00 -17:00    Session II: Virus vaccines and vaccine biology

Vesna Blazevic (University of Tampere): Combination vaccine of norovirus virus-like particles and rotavirus VP6 protein for childhood gastroenteritis.
Markus Vähä-Koskela (University of Helsinki): Feasibility and mechanisms of heterologous adeno-poxvirus combination virotherapy.
Ilkka Julkunen (THL): Pandemic influenza vaccine -associated  narcolepsy in Finland.
Mari Strengell (THL): Antibody responses against influenza A(H1N1)pdm09 virus after vaccination with pandemic and seasonal influenza vaccines.
Maria Hemming (University of Tampere School of Medicine): Vaccine derived bovine rotavirus double reassortant in infants with acute gastroenteritis.
Mia Kontio (THL): The return of measles.

17:00 -18:30    Free time
18:30 -19:30    Posters, exhibiton and cocktails
19:30 -             Dinner

Friday, 23 March 2012

09:00-10:00    Session III: Clinical virology 1

Petri Susi (University of Turku): Optimization of quantitative RT-PCR for enterovirus typing.
Markos Mölsä (Centres for Military Medicine and for Biological Threat Preparedness, Helsinki): Genotyping of adenoviruses circulating among Finnish military conscripts.
Minna Ylihärsilä (University of Turku):  Genotyping of clinically relevant human adenoviruses by array-in-well hybridization assay.
Sisko Tauriainen (University of Tampere): Antibody prevalence against different parechovirus types.

10:00-10:30    Coffee break and exhibition
10:30-12:00    Session IV: Clinical virology 2

Klaus Hedman (University of Helsinki): Emerging human polyomaviruses.
Tuija Kekarainen (Centre de Recerca en Sanitat Animal, Barcelona): Recent advances on pig infecting single stranded circular DNA viruses.
Elina Tonteri (University of Helsinki): Tick-borne encephalitis virus persiststence in bank voles.
Aaro Turunen (University of Turku): The combined irradiation and herpes simplex virus type 1 infection on an immortal gingival cell line.

12:00-13:00    Lunch
13:00-14:30    Session V: Molecular virology 2
                       Session VI: New perspectives in virology

Ilona Rissanen (University of Jyväskylä): Novel capsid organization revealed in the newest member of the double β-barrel lineage.
Teemu Smura (THL): Evolutionary patterns of enterovirus 5’ non-coding region.
Niina Ikonen (THL): Molecular characterisation of influenza A(H1N1)pdm09 viruses in Finland.
Oxana Denisova (University of Helsinki): Novel strategy for treatment of influenza A virus infections. 
Paula M. Kinnunen (Centre for Military Medicine, Helsinki):  Safe from biothreats? Legislation protects you and society.

14:30-14:40    Closing remarks